[CYCC] YoY Annual Result on 31-Dec-2011 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
30-Mar-2012
Financial Year
2011
Quarter
31-Dec-2011 [#FY]
Profit Trend
YoY- 4.86%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 1,734 1,084 69 699 686 911 877 12.02%
PBT -22,649 -11,880 -15,107 -15,808 -16,678 -20,518 -42,135 -9.82%
Tax -3,243 -1,670 -1,351 -565 -657 -948 -1,749 10.83%
NP -19,387 -10,153 -13,186 -15,243 -16,021 -19,570 -40,386 -11.50%
Tax Rate - - - - - - - -
Total Cost 21,121 11,237 13,255 15,942 16,707 20,481 41,263 -10.55%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -1,118.05 -936.62 -19,110.14 -2,180.69 -2,335.42 -2,148.19 -4,605.02 -21.00%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -211.93 -160.75 -440.40 -509.10 -711.22 -1,481.23 -3,320.67 -36.77%
EPS Diluted -211.93 -160.75 -440.40 -509.10 -711.22 -1,481.23 -3,320.67 -36.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.